Hormel Foods reported QQ1 2025 net sales of $3.0 billion, up 1% on an organic basis, led by strength in the value-added portfolio across Retail, Foodservice, and International segments. Gross margin declined to 15.9%, pressured by Planters brand recovery, higher input costs (pork, beef, nuts) and supply chain headwinds from bird illnesses, with operating margin at 7.64% and net income of $170.6 million ($0.31 per diluted share). Management reaffirmed full-year guidance of 1% to 3% organic net sales growth and adjusted diluted EPS of $1.58 to $1.72, signaling a constructive but cautious tone given near-term turkey dynamics. The company continues to invest in brands (advertising expense ~ $43 million in Q1) and in Transform and Modernize (T&M), targeting $100–$150 million in additional benefits in 2025 and a path to long-term earnings growth through a growth flywheel. Planters recovery is a core near-term driver in retail, with broad-based growth anticipated in other segments in the second half. Management highlighted an ongoing CEO succession process with emphasis on rigor and internal/external candidate evaluation, while remaining focused on executing the strategic initiatives that underpin the 2025 and 2026 targets despite near-term margin pressures from turkey dynamics.